Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.
cancer genetic counseling
multigene-panel testing
patient reported outcomes
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
03
07
2020
revised:
15
07
2020
accepted:
17
07
2020
pubmed:
28
8
2020
medline:
16
10
2021
entrez:
28
8
2020
Statut:
ppublish
Résumé
The study describes patient-reported experiences and recommendations to improve the genetic counseling and multigene panel testing (MGPT) process. A descriptive mixed-method study with concurrently collected and integrated qualitative and quantitative data was conducted. Eligible participants were English-speaking adults with a breast or gynecologic cancer diagnosis who had received genetic counseling and testing with a MGPT from one Comprehensive Cancer Center. Satisfaction with the genetic counseling, genetic knowledge using a recently validated scale (KnowGene), the multidimensional impact of cancer risk assessment (MICRA), family communication, and the association with demographic factors were evaluated. To supplement the large quantitative data set, qualitative focus group responses and open-ended text items were collected. Univariate and multivariable associations between each outcome of interest and personal characteristics were assessed. Qualitative data were content-analyzed. 603 participants completed the survey (48% response rate) and 10 individuals participated in the focus groups. Participants were mostly Caucasian, educated with a college degree or more, and female with median age 58 (24-91), and 78% of participants had a breast cancer diagnosis. Of all individuals undergoing genetic testing using a MGPT, 13% had a pathogenic variant identified, and 30% had a variant of uncertain significance (VUS). Overall, participants reported satisfaction with the genetic counseling and testing process (mean 36.9 [SD 4.7]). On average, participants had 7 incorrect answers out of 19 on the genetic knowledge scale (mean 12.3 [SD 3.4]). MICRA scores showed overall low levels of distress and uncertainty, as well as positive experiences, with wide variability (median 17 [0-84]). Age, marital status, education level, type of cancer diagnosis, and genetic testing results were significantly associated with outcomes. Most participants communicated genetic testing results to mainly female first-degree relatives. A wide range of individual preferences affecting overall satisfaction, or suggestions for improvement were shared. As new models of streamlined cancer genetic services are being clinically implemented, approaches should continue to assess and tailor the process based on patients' informational and emotional needs.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
268-282Informations de copyright
© 2020 National Society of Genetic Counselors.
Références
Bradbury, A. R., Patrick-Miller, L., Long, J., Powers, J., Stopfer, J., Forman, A., … Chambers, R. (2015). Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genetics in Medicine, 17(6), 485-492.
Bradbury, A. R., Patrick-Miller, L. J., Egleston, B. L., DiGiovanni, L., Brower, J., Harris, D., … Chavez, T. (2016). Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine, 18(1), 25-33.
Cella, D., Hughes, C., Peterman, A., Chang, C.-H., Peshkin, B. N., Schwartz, M. D., … Lerman, C. (2002). A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology, 21(6), 564.
Colombo, N., Huang, G., Scambia, G., Chalas, E., Pignata, S., Fiorica, J., … Blakeley, C. (2018). Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer. Journal of Clinical Oncology, 36(13), 1300-1307. https://doi.org/10.1200/JCO.2017.76.2781.
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., … Khan, S. (2016). Genetic/familial high-risk assessment: breast and ovarian, version 2.2015. Journal of the National Comprehensive Cancer Network, 14(2), 153-162.
Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., … Ellisen, L. W. (2015). Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment multigene panel testing for breast and ovarian cancer risk assessment multigene panel testing for breast and ovarian cancer risk assessment. JAMA Oncology, 1(7), 943-951. https://doi.org/10.1001/jamaoncol.2015.2690.
Esteban, I., Vilaró, M., Adrover, E., Angulo, A., Carrasco, E., Gadea, N., … Balmaña, J. (2018). Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psycho-Oncology, 27(6), 1530-1537. https://doi.org/10.1002/pon.4686.
Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., … Domchek, S. M. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81-91.
Geus, E., Eijzenga, W., Menko, F. H., Sijmons, R. H., Haes, H. C., Aalfs, C. M., & Smets, E. M. (2016). Design and feasibility of an intervention to support cancer genetic counselees in informing their at-risk relatives. Journal of Genetic Counseling, 25, 1-9.
Graffeo, R., Livraghi, L., Pagani, O., Goldhirsch, A., Partridge, A. H., & Garber, J. E. (2016). Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Research and Treatment, 160(3), 393-410. https://doi.org/10.1007/s10549-016-4003-9.
Graves, K. D., Gatammah, R., Peshkin, B. N., Krieger, A., Gell, C., Valdimarsdottir, H. B., & Schwartz, M. D. (2011). BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Familial Cancer, 10(2), 213-223.
Gray, S. W., Martins, Y., Feuerman, L. Z., Bernhardt, B. A., Biesecker, B. B., Christensen, K. D., … McGuire, A. L. (2014). Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group. Genetics in Medicine, 16(10), 727-735.
Hall, M. J., Patrick-Miller, L. J., Egleston, B. L., Domchek, S. M., Daly, M. B., Ganschow, P., … Bradbury, A. R. (2018). Use and patient-reported outcomes of clinical multigene panel testing for cancer susceptibility in the multicenter communication of genetic test results by telephone study. JCO Precision Oncology, 2, https://doi.org/10.1200/po.18.00199.
Hann, K. E. J., Freeman, M., Fraser, L., Waller, J., Sanderson, S. C., Rahman, B., … Lanceley, A. (2017). Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health, 17(1), 503. https://doi.org/10.1186/s12889-017-4375-8.
Jacobs, C., Patch, C., & Michie, S. (2019). Communication about genetic testing with breast and ovarian cancer patients: a scoping review. European Journal of Human Genetics, 27(4), 511-524. https://doi.org/10.1038/s41431-018-0310-4.
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., … Lincoln, S. E. (2014). Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. Journal of Clinical Oncology, 32(19), 2001.
Légaré, F., Robitaille, H., Gane, C., Hébert, J., Labrecque, M., & Rousseau, F. (2016). Improving decision making about genetic testing in the clinic: An overview of effective knowledge translation interventions. PLoS One, 11(3), e0150123.
McLafferty, I. (2004). Focus group interviews as a data collecting strategy. Journal of Advanced Nursing, 48(2), 187-194. https://doi.org/10.1111/j.1365-2648.2004.03186.x.
Nelson, H. D., Pappas, M., Cantor, A., Haney, E., & Holmes, R. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA, 322(7), 666-685.
Nilsson, M. P., Nilsson, E. D., Borg, A., Brandberg, Y., Silfverberg, B., & Loman, N. (2019). High patient satisfaction with a simplified BRCA1/2 testing procedure: Long-term results of a prospective study. Breast Cancer Research and Treatment, 173(2), 313-318. https://doi.org/10.1007/s10549-018-5000-y.
Nilsson, M. P., Torngren, T., Henriksson, K., Kristoffersson, U., Kvist, A., Silfverberg, B., … Loman, N. (2018). BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer. Breast Cancer Research and Treatment, 168(1), 117-126. https://doi.org/10.1007/s10549-017-4584-y.
Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700-706. https://doi.org/10.1200/jco.2005.01.7541.
Plon, S. E., Cooper, H. P., Parks, B., Dhar, S. U., Kelly, P. A., Weinberg, A. D., … Hilsenbeck, S. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148-154.
Quinn, V. F., Meiser, B., Kirk, J., Tucker, K. M., Watts, K. J., Rahman, B., … Mitchell, G. (2017). Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial. Genetics in Medicine, 19(4), 448-456. https://doi.org/10.1038/gim.2016.130.
Scherr, C. L., Christie, J., & Vadaparampil, S. T. (2016). Breast cancer survivors' knowledge of hereditary breast and ovarian cancer following genetic counseling: An exploration of general and survivor-specific knowledge items. Public Health Genomics, 19(1), 1-10. https://doi.org/10.1159/000439162.
Schwartz, M. D., Peshkin, B. N., Isaacs, C., Willey, S., Valdimarsdottir, H. B., Nusbaum, R., … Khoury, K. (2018). Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients. Breast Cancer Research and Treatment, 170(3), 517-524. https://doi.org/10.1007/s10549-018-4773-3.
Underhill-Blazey, M., Stopfer, J., Chittenden, A., Nayak, M. M., Lansang, K., Lederman, R., … Gundersen, D. A. (2019). Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Education and Counseling, 102(8), 1558-1564. https://doi.org/10.1016/j.pec.2019.04.014.